This topic contains a solution. Click here to go to the answer

Author Question: A technical document focuses on (a) the subject, (b) the writers feelings, (c) both the subject ... (Read 81 times)

deesands

  • Hero Member
  • *****
  • Posts: 514
A technical document focuses on
 
  (a) the subject, (b) the writers
  feelings, (c) both the subject and the writers feelings, (d)
  marketing, or (e) none of the above.

Question 2

Clarity in technical communication
  means the same thing to all people.
 
  Indicate whether the statement is true or false.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

nickk12214

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

a

Answer to Question 2

F




deesands

  • Member
  • Posts: 514
Reply 2 on: Jul 20, 2018
:D TYSM


mcarey591

  • Member
  • Posts: 365
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

Chronic necrotizing aspergillosis has a slowly progressive process that, unlike invasive aspergillosis, does not spread to other organ systems or the blood vessels. It most often affects middle-aged and elderly individuals, spreading to surrounding tissue in the lungs. The disease often does not respond to conventionally successful treatments, and requires individualized therapies in order to keep it from becoming life-threatening.

Did you know?

Bacteria have flourished on the earth for over three billion years. They were the first life forms on the planet.

Did you know?

Complications of influenza include: bacterial pneumonia, ear and sinus infections, dehydration, and worsening of chronic conditions such as asthma, congestive heart failure, or diabetes.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library